Domoco
Timeline
20 events since 2018Board
Capital
Filings
Financial
Establishments
Address
20182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBfull format · 39 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0707700914
2025
2 directors appointed, 2 resignationsResignations: MEDICAL PARTNERS NV and Thomas VANDERERFVEN · Permanent representatives: DE QUINNEMAR Cédric and Piet VAN WAES · Appointments: QUINNCO BV and TILLINVEST BV6 points ▸
- Director resignation, MEDICAL PARTNERS NV
- Permanent representative, DE QUINNEMAR Cédric, mentioned twice in the deed
- Director appointment, QUINNCO BV
- Director resignation, Thomas VANDERERFVEN
- Director appointment, TILLINVEST BV
- Permanent representative, Piet VAN WAES
Annual accounts 2024 filed PDFfull format · 29 days before the deadline
Amendment of the articlesCatharina De Schipper is a shareholder · General meeting of 25-02-20253 points ▸
- General meeting, 25-02-2025
- Catharina De Schipper is a shareholder
- Power of attorney, Stijn RAES
- The deed holds 5 more points.
2024
Amendment of the articles · Legal-form changeGeneral meeting of 29-11-20241 point ▸
- General meeting, 29-11-2024
- The deed holds 4 more points.
Permanent representative: PietVANWAESBoard meeting of 30-11-20243 points ▸
- Board meeting, 30-11-2024
- Registered-office move, 9800DEINZE, VaartRechteroever49-51
- Permanent representative, PietVANWAES
Annual accounts 2023 filed PDFfull format · 13 days before the deadline
2023
Liquidity more than 43 times current ratio 18.38 The current ratio rises from 0.42 to 18.38. Short-term debt falls from €1.1m to €79,000.
Annual accounts 2022 filed PDFfull format · 13 days before the deadline
2022
Merger: DOMOCO takes over GHECOMResignations: TILLINVEST, MEDICAL PARTNERS, VANDERERFVEN Thomas Jozef Elizabeth and SERENGETI · Reappointments: TILLINVEST, MEDICAL PARTNERS and VANDERERFVEN Thomas Jozef Elizabeth · Appointment: FELICO (director) · General meeting of 01-08-202216 points ▸
- General meeting, 01-08-2022
- Dissolution, merger
- Accounting effect, 01-01-2022
- 1,500 shares
- Director resignation, TILLINVEST
- Director resignation, MEDICAL PARTNERS
- Director resignation, VANDERERFVEN Thomas Jozef Elizabeth
- Director resignation, SERENGETI
- Director reappointment, TILLINVEST (director (not named in the articles))
- Director reappointment, MEDICAL PARTNERS (director (not named in the articles))
- Director reappointment, VANDERERFVEN Thomas Jozef Elizabeth (director (not named in the articles))
- Director appointment, FELICO (director (not named in the articles))
- Permanent representative, DE QUINNEMAR Cédric Carlos Martine
- Permanent representative, Catharina De Schipper
- Permanent representative, Piet Van Waes
- Registered office clause, Vaartlaan 9, 9800 Deinze
- The deed holds 7 more points.
Annual accounts 2021 filed PDFfull format · 46 days before the deadline
Merger proposal: DOMOCO BV takes over GHECOM BVPermanent representatives: Piet VAN WAES, Catharina DE SCHIPPER and Cédric DE QUINNEMAR · Appointments: TILLINVEST BV, SERENGETI BV and DOMOCO BV · The company holds all the shares of GHECOM BV · Board meeting of 05-05-202219 points ▸
- Board meeting, 05-05-2022
- Permanent representative, Piet VAN WAES, mentioned 3 times in the deed
- Permanent representative, Catharina DE SCHIPPER, mentioned 3 times in the deed
- Director appointment, TILLINVEST BV
- Director appointment, SERENGETI BV, mentioned twice in the deed
- Director appointment, DOMOCO BV
- The company holds all the shares of GHECOM BV, mentioned twice in the deed
- Capital, €3,000,000, 1,500 shares
- Board composition, TILLINVEST BV (director)
- Board composition, MEDICAL PARTNERS NV (director), mentioned twice in the deed
- Permanent representative, Cédric DE QUINNEMAR, mentioned twice in the deed
- Board composition, SERENGETI BV (director), mentioned twice in the deed
- Board composition, Thomas VANDERERFVEN (director), mentioned twice in the deed
- Catharina DE SCHIPPER holds 500 shares
- TILLINVEST BV holds 350 shares
- MEDICAL PARTNERS NV holds 500 shares
- NEOMIS BV holds 150 shares
- Capital, €2,534,636.60, 40,500 shares
- Accounting effect, 01-01-2022
- The deed holds 12 more points.
2021
Highest result from 2019 to 2025 net €3.2m ▲10,594% The net result of €3.2m is the highest of those years.
Equity above €5m equity €6.0m ▲115% After 2 profitable years in a row, equity reaches €6.0m.
Annual accounts 2020 filed PDFfull format · 47 days before the deadline
2020
Back to profit net €30,234 The net result is €30,234, after one loss-making year.
Annual accounts 2019 filed PDFfull format · 83 days late
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank